Clinical trial
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2…
NCT00418041 · Hiroaki Shimokawa, MD, PhD, Other · Unknown status
Key facts
| NCT number | NCT00418041 |
|---|---|
| Title | Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) |
| Official title | Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) |
| Lead sponsor | Hiroaki Shimokawa, MD, PhD, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Heart Failure, Coronary Disease, Heart Valve Diseases, Cardiomyopathies, Left Ventricular Hypertrophy |
| Enrollment | 10,000 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2019 |
| Completion | Dec 1, 2019 |
| First posted | Jan 4, 2007 |
| Last update posted | May 12, 2015 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: